This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy.

This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.

This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.

This Technical Brief describes promising and innovative medication-assisted treatment (MAT) models of care in primary care settings, describe barriers to MAT implementation, summarize the evidence available on MAT models of care in primary care settings, identifies gaps in the evidence base, and guides future research.

This toolkit supports a structured, team-based approach to improving the management of patients who take opioids to ease chronic pain.

This guide describes core elements of screening, brief intervention, and referral to treatment (SBIRT) programs for people living with or at risk for substance use disorders.

This manual offers guidance to clinicians on implementing drug testing in their practice. It presents the mechanics of testing, and outlines steps for preparing staff to carry out this work.

This guide is designed to help an individual or small planning team adapt alcohol SBI to the unique operational realities of their primary care practice.

This list of resources, put forth by the SAMHSA-HRSA Center for Integrated Health Solutions (CIHS), assists providers in integrating primary and behavioral health services to better address the needs of individuals with mental health and substance use conditions, whether seen in specialty behavioral health or primary care provider settings.

The AHRQ academy, which is a national resource for integrating behavioral health and primary care, offers guidance on how to integrate behavioral health and medication-assisted treatment for opioid use disorder into primary care or other ambulatory care settings to improve healthcare delivery and to achieve better patient outcomes.

This report provides behavioral health professionals, researchers, policymakers and other audiences with a comprehensive research overview and accurate information about effective and ineffective therapeutic practices related to youth of diverse sexual orientation and gender identity.

This literature review provides a summary of the behavioral health implications regarding Long COVID. It describes an overview of behavioral health disorders associated with Long COVID, neuropsychiatric causes of the behavioral health disorders, and future research needs.

The American Society of Addiction Medicine (ASAM) developed this pocket guide for healthcare providers which provides instant access to key information in The ASAM Appropriate Use of Testing in Clinical Addiction Medicine in a clear and concise format.

The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision-making and management of patients experiencing alcohol withdrawal syndrome.

This pocket guide was produced by the American Society of Addiction Medicine (ASAM) and the National Association of Drug Court Professionals (NADCP) and is designed to help counselors and therapists working with drug court participants refer and link participants to opioid treatment services in outpatient offices, clinics, and Opioid Treatment Programs (OTPs).

This pocket guide was produced by the American Society of Addiction Medicine (ASAM) and the National Association of Drug Court Professionals (NADCP) guide.